Page last updated: 2024-08-18

arginine vasopressin and MS (Multiple Sclerosis)

arginine vasopressin has been researched along with MS (Multiple Sclerosis) in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19903 (42.86)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hertogs, K; Hilton, P; Stanton, SL1
Akerlund, M; Forsling, ML; Olsson, JE; Sundquist, J1
Hofman, MA; Kamphorst, W; Polman, CH; Purba, JS; Raadsheer, FC; Ravid, R; Swaab, DF1
Chrousos, GP; Galliven, E; Gold, PW; Magiakou, MA; Michelson, D; Sternberg, EM; Stone, L1
Gold, PW; Michelson, D1
Dobrov, SA; Golovkin, VI; Iampol'skaia, LI; Korovin, KF1
Gjerris, A; Hammer, M; Sørensen, PS1

Other Studies

7 other study(ies) available for arginine vasopressin and MS (Multiple Sclerosis)

ArticleYear
The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.
    Journal of neurology, neurosurgery, and psychiatry, 1983, Volume: 46, Issue:9

    Topics: Arginine Vasopressin; Deamino Arginine Vasopressin; Double-Blind Method; Female; Humans; Multiple Sclerosis; Urination Disorders

1983
Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases.
    Journal of neurology, neurosurgery, and psychiatry, 1983, Volume: 46, Issue:1

    Topics: Adolescent; Adult; Aged; Arginine Vasopressin; Blood-Brain Barrier; Cerebrovascular Disorders; Dementia; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Nervous System Diseases; Parkinson Disease

1983
Increased number of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis.
    Neuroendocrinology, 1995, Volume: 62, Issue:1

    Topics: Adult; Arginine Vasopressin; Cell Count; Corticotropin-Releasing Hormone; Female; Humans; Hypothalamus; Immunohistochemistry; Male; Middle Aged; Multiple Sclerosis; Neurons; Paraventricular Hypothalamic Nucleus

1995
Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function.
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 79, Issue:3

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Arginine Vasopressin; Corticotropin-Releasing Hormone; Cytokines; Female; Humans; Hydrocortisone; Hypothalamus; Male; Multiple Sclerosis; Pituitary Gland; Recurrence; Remission Induction

1994
Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depression.
    Annals of the New York Academy of Sciences, 1998, May-01, Volume: 840

    Topics: Adrenocorticotropic Hormone; Arginine Vasopressin; Bone Density; Depression; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Multiple Sclerosis; Pituitary-Adrenal System

1998
[Neuroendocrine aspects of the pathogenesis and treatment of disseminated sclerosis and lateral amyotrophic sclerosis].
    Sovetskaia meditsina, 1990, Issue:5

    Topics: Adult; Amyotrophic Lateral Sclerosis; Arginine Vasopressin; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Prognosis; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine

1990
Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.
    Journal of neurology, neurosurgery, and psychiatry, 1985, Volume: 48, Issue:1

    Topics: Adult; Aged; Arginine Vasopressin; Basal Ganglia Diseases; Bipolar Disorder; Brain Diseases; Brain Neoplasms; Cerebral Hemorrhage; Cerebral Infarction; Dementia; Depressive Disorder; Female; Humans; Hydrocephalus; Hydrocephalus, Normal Pressure; Intracranial Pressure; Male; Mental Disorders; Middle Aged; Multiple Sclerosis; Pseudotumor Cerebri; Schizophrenia

1985